Terms: = Cervical cancer AND TET1, KIAA1676, 80312, ENSG00000138336, CXXC6, bA119F7_1, Q8NFU7, LCX AND Treatment
10775 results:
1. Insights into pelvic insufficiency fracture following pelvic radiotherapy for cervical cancer: a comparative review.
Haque M; Hossen MS
BMC Womens Health; 2024 May; 24(1):306. PubMed ID: 38783273
[TBL] [Abstract] [Full Text] [Related]
2. Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
Broshkevitch CJ; Barnabas RV; Liu G; Palanee-Phillips T; Rao DW
PLoS One; 2024; 19(5):e0301997. PubMed ID: 38781268
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence of high-risk human papillomavirus genotypes in outpatient Malian women living with HIV: a pilot study.
Traore B; Kassogue Y; Diakite B; Diarra F; Cisse K; Kassogue O; Diarra M; Coulibaly A; Coulibaly B; Diallo H; Diarra Z; Ly M; Maiga A; Sissoko SB; Sissoko AS; Traore CB; Kamate B; Teguete I; Bah S; Dolo G; Gursel DB; Holl J; Hou L; Maiga M
BMC Infect Dis; 2024 May; 24(1):513. PubMed ID: 38778266
[TBL] [Abstract] [Full Text] [Related]
4. Primary Ewing's sarcoma of the uterine cervix: a case report and review of the literature.
Xiao Y; Zhi Y; Cao G; Ma H; Gao J; Li F
J Cancer Res Clin Oncol; 2024 May; 150(5):267. PubMed ID: 38769118
[TBL] [Abstract] [Full Text] [Related]
5. Assessing the reduction of viral infectivity in HPV16/18-positive women after one, two, and three doses of Gardasil-9 (RIFT): Study protocol.
López-Codony V; de Andrés-Pablo Á; Ferrando-Díez A; Fernández-Montolí ME; López-Querol M; Tous S; Ortega-Expósito C; Torrejón-Becerra JC; Pérez Y; Ferrer-Artola A; Sole-Sedeno JM; Grau C; Rupérez B; Saumoy M; Sánchez M; Peremiquel-Trillas P; Bruni L; Alemany L; Bosch FX; Pavón MA
PLoS One; 2024; 19(5):e0304080. PubMed ID: 38768231
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
Dong B; Zhou SF
BMC Womens Health; 2024 May; 24(1):297. PubMed ID: 38762459
[TBL] [Abstract] [Full Text] [Related]
7. Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations.
Rached L; Laparra A; Sakkal M; Danlos FX; Barlesi F; Carbonnel F; De Martin E; Ducreux M; Even C; Le Pavec J; Michot JM; M Ribeiro J; Scotte F; Ponce Aix S; Lambotte O; Baldini C; Champiat S
Cancer Treat Rev; 2024 Jun; 127():102751. PubMed ID: 38729086
[TBL] [Abstract] [Full Text] [Related]
8. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
Lei L; Zhang L; Zheng Y; Ma W; Liu F; Li D; Chen K; Zeng Y
BMC Cancer; 2024 May; 24(1):575. PubMed ID: 38724921
[TBL] [Abstract] [Full Text] [Related]
9. EPAS1, a hypoxia- and ferroptosis-related gene, promotes malignant behaviour of cervical cancer by ceRNA and super-enhancer.
Lu X; Zhang W; Zhang J; Ren D; Zhao P; Ying Y
J Cell Mol Med; 2024 May; 28(9):e18361. PubMed ID: 38722283
[TBL] [Abstract] [Full Text] [Related]
10. Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis.
Zeng F; Guo P; Xia M; He M
J Cancer Res Clin Oncol; 2024 May; 150(5):236. PubMed ID: 38710946
[TBL] [Abstract] [Full Text] [Related]
11. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
Newton C; Graham R; Liberale V; Burnell M; Menon U; Mould T; Olaitan A; Macdonald N; Widschwendter M; Doufekas K; McCormack M; Mitra A; Arora R; Manchanda R
J Obstet Gynaecol; 2024 Dec; 44(1):2344529. PubMed ID: 38708782
[TBL] [Abstract] [Full Text] [Related]
13. Using electronic health records to evaluate the adherence to cervical cancer prevention guidelines: A cross-sectional study.
Mooses K; Šavrova A; Pajusalu M; Oja M; Tamm S; Haug M; Padrik L; Laanpere M; Uusküla A; Kolde R
Prev Med; 2024 Jun; 183():107982. PubMed ID: 38701952
[TBL] [Abstract] [Full Text] [Related]
14. cancer incidence, treatment, and survival in the prison population compared with the general population in England: a population-based, matched cohort study.
Lüchtenborg M; Huynh J; Armes J; Plugge E; Hunter RM; Visser R; Taylor RM; Davies EA
Lancet Oncol; 2024 May; 25(5):553-562. PubMed ID: 38697154
[TBL] [Abstract] [Full Text] [Related]
15. [cervical CUP Syndrome: Diagnosis and Therapy].
Lammert A; Abo-Madyan Y; Huber L; Ludwig S; Scherl C; Rotter N
Laryngorhinootologie; 2024 May; 103(5):371-382. PubMed ID: 38697084
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
Zhou Y; Wang W; Tang J; Hu K; Zhang F
BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
[TBL] [Abstract] [Full Text] [Related]
17. Identification and Quantification of Radiotherapy-related Protein Expression in cancer Tissues Using the Qupath Software and Prediction of treatment Response.
Hasegawa T; Someya M; Tsuchiya T; Kitagawa M; Fukushima Y; Gocho T; Mafune S; Okuda R; Kaguchi J; Ohguro A; Kamiyama R; Ashina A; Toshima Y; Hirohashi Y; Torigoe T; Sakata KI
In Vivo; 2024; 38(3):1470-1476. PubMed ID: 38688633
[TBL] [Abstract] [Full Text] [Related]
18. Radiotherapy for patients with esophageal cancer aged 80 years or older: A 16-year experience.
Zhai T; Huang R; Zhan Y; Xu L; Yu Y; Guo L; Chen J; Su C; Chen C
J Cancer Res Ther; 2024 Apr; 20(2):678-683. PubMed ID: 38687940
[TBL] [Abstract] [Full Text] [Related]
19. IRAK1 deficiency potentiates the efficacy of radiotherapy in repressing cervical cancer development.
Chen W; Xie X; Liu C; Liao J; Wei Y; Wu R; Hong J
Cell Signal; 2024 Jul; 119():111192. PubMed ID: 38685522
[TBL] [Abstract] [Full Text] [Related]
20. [Effect of COVID-19 pandemics in treatment of cervical cancer: pre/post study].
Arrossi S; Binder F; Ituarte C; Martiarena N; Campanera A; Bárcena M; Paolino M
Medicina (B Aires); 2024; 84(2):236-248. PubMed ID: 38683508
[TBL] [Abstract] [Full Text] [Related]
[Next]
